NCCN Patient Webinar: Pediatric Acute Lymphoblastic Leukemia

Experts discuss how to understand the diagnosis and treatment of pediatric acute lymphoblastic leukemia, how to engage in shared decision-making with your care team, and side effects, clinical trials, and available patient and caregiver resources.

Topics Discussed:
00:00 Welcome and introductions
02:24 Clinical overview of pediatric acute lymphoblastic leukemia (ALL)
04:14 How does ALL happen in bone marrow?
06:04 How do we diagnose ALL?
07:54 Incidence of ALL
08:41 Medications used in ALL therapy
09:37 Improved survival in ALL
10:07 Risk stratification of ALL
11:11 Genetic analysis and genetic subtypes of ALL
12:19 Response to therapy: Minimal residual disease (MRD)
14:31 Adverse effects in ALL therapy and individual chemotherapy modification
17:17 New therapeutic approaches of ALL
22:26: Recent research studies on ALL treatment
24:55 Supportive care
26:02 Side effects
27:29 Low blood counts
29:07 Infections
30:07 Fever and how to take a temperature
31:35 Impact on skin, hair, and mucus membranes
33:30 Nutrition
34:45 Nausea and vomiting
35:47 Pain and "chemo brain"
37:50 Side effects of steroids
39:14 Vincristine side effects
40:13 Asparaginase side effects
42:07 Immunotherapy side effects
44:23 Patient story
51:19 Advocating for your child with cancer: Ask questions, share your concerns, get organized, communicate with your child, take care of yourself, find support

Question & Answer Session:
55:33 How can children have their own support group?
57:07 Is there a male predisposition to ALL?
58:12 Can other countries have access to immunotherapy or molecular targeted therapy?
59:56 Do you often get questions from providers around the world?
1:00:48 What can we do during treatment to reduce the risk of long-term side effects like heart disease, secondary cancer, etc.?
1:02:48 Should patients avoid multivitamins or certain types of foods during treatment?
1:04:32 How do we measure progress during treatment or effectiveness of the chemotherapy medications?
1:05:35 Any pearls to offer on the use of serum asparaginase activity testing and when to consider changing therapy?
1:06:46 Can you explain half life? Do the side effects continue because of the drug half life?
1:07:38 When you are taken off a drug due to side effects, such as pancreatitis, what does this mean?
1:09:35 Is there a clinical trial about blinatumomab as first-line treatment?
1:10:38 Conclusion

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgement of the clinician.

Supporters
This webinar is supported through the NCCN Foundation and by contributions from our corporate supporters, Amgen Inc. and Jazz Pharmaceuticals, Inc.

__________________________________________________________
About NCCN Foundation®:
__________________________________________________________
About NCCN:

Connect with us!